#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10646	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2120	495.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	588	C	574	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10646	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2120	495.9	0	HET	.	.	.	C451T	.	451	451	C	689	689	C	631	C,T	468,141	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10646	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2120	495.9	0	HET	.	.	.	C207T,G	.	207	207	C	445	445	C	620	C,T,G	459,137,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3512	554.9	0	.	n	.	0	T695C	SNP	695	695	T	1024	1024	C	610	C	594	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3512	554.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2300	2300	C	613	C	589	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3512	554.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2374	2374	A	608	A	595	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3512	554.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2926	2926	C	654	C,T	637,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	19680	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3512	554.9	0	HET	.	.	.	A1638G	.	1638	1638	A	1967	1967	A	564	A,G	286,266	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	14	blaTEM	861	391	100.0	blaTEM.l6.c4.ctg.1	452	2.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1356	folP	855	855	100.0	folP.l15.c4.ctg.1	1532	87.5	1	SNP	p	R229S	1	.	.	685	687	AGC	968	970	AGC	136;136;132	A;G;C	134;131;124	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4040	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3466	115.8	1	SNP	p	S91F	1	.	.	271	273	TTC	605	607	TTC	154;154;154	T;T;C	153;154;150	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4040	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3466	115.8	1	SNP	p	G95N	0	.	.	283	285	GGC	617	619	GGC	152;153;151	G;G,T,A;C	149;150,1,1;148	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4040	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3466	115.8	1	SNP	p	D95G	1	.	.	283	285	GGC	617	619	GGC	152;153;151	G;G,T,A;C	149;150,1,1;148	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1286	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1345	95.0	1	SNP	p	G45D	0	.	.	133	135	GGC	478	480	GGC	151;152;151	G;G;C	146;146;145	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	646	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1076	59.7	0	.	n	.	0	A197.	DEL	197	197	A	654	654	A	151	A	147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3532	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3036	115.6	1	SNP	p	D86N	0	.	.	256	258	GAC	551	553	GAC	148;151;151	G;A;C	142;141;147	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3532	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3036	115.6	1	SNP	p	S87R	1	.	.	259	261	CGT	554	556	CGT	149;148;150	C,A;G;T	145,1;146;146	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3532	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3036	115.6	1	SNP	p	R87I	0	.	.	259	261	CGT	554	556	CGT	149;148;150	C,A;G;T	145,1;146;146	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3532	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3036	115.6	1	SNP	p	R87W	0	.	.	259	261	CGT	554	556	CGT	149;148;150	C,A;G;T	145,1;146;146	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3532	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3036	115.6	1	SNP	p	S88P	0	.	.	262	264	TCC	557	559	TCC	150;148;149	T;C;C	146;145;147	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2934	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2729	106.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1588	1590	GGC	158;157;156	G;G;C	155;154;151	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1163	1165	GCC	191;191;191	G;C;C	186;188;186	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1166	1168	ATG	193;190;191	A;T;G	190;186;187	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1178	1180	ACC	185;183;185	A,C;C;C	175,1;180;183	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1178	1180	ACC	185;183;185	A,C;C;C	175,1;180;183	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1679	1681	ACC	149;150;151	A,T;C;C	143,1;147;148	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1733	1735	GCG	153;152;153	G;C;G	149;148;150	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1733	1735	GCG	153;152;153	G;C;G	149;148;150	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1856	1858	GGT	114;115;115	G,A;G;T	109,1;111;110	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1865	1867	AGC	108;107;106	A;G;C	104;101;102	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3082	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2256	134.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1883	1885	CCG	86;90;90	C,G;C,G;G	79,1;83,1;81	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4000	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3040	130.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	141;142;138	C;C;G,T	133;139;131,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1690	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1777	93.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	503	503	C	114	C	110	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	605	607	AGC	145;146;147	A;G,C;C	140;142,1;141	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	697	698	CG	178;177	C;G,A	173;172,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	700	702	CAG	174;174;174	C,G,T;A,G;G,C,A	168,1,1;167,3;167,2,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	704	706	AAA	175;175;174	A;A;A,C	173;173;165,4	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	731	733	TAT	184;181;180	T;A,T;T	178;175,2;176	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	N134E	NONSYN	400	402	AAT	740	742	GAG	170;171;174	G,A;A;G,T	164,2;165;168,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	V135F	NONSYN	403	405	GTG	743	745	TTT	174;173;177	T,G;T;T,G	161,2;167;167,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	758	760	AAA	177;176;175	A,G;A,G;A	172,1;171,1;170	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	767	769	GAA	173;174;176	G,C;A,G;A	166,1;165,1;167	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	791	793	GCA	172;173;173	G;C,T;A	163;163,1;166	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	Y212R	NONSYN	634	636	TAT	974	976	CGT	171;170;169	C,T;G,A;T	165,1;165,1;159	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	T213L	NONSYN	637	639	ACA	977	979	TTA	172;172;173	T,G;T,C;A	164,1;164,1;165	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	.	MULTIPLE	760	761	AC	1100	1102	GCA	160;158;161	G;C;A	154;151;156	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	0	.	p	.	0	W255fs	FSHIFT	763	763	T	1104	1104	T	162	T,C,G	154,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	1	SNP	p	G120K	1	.	.	358	360	AAG	697	699	CGG	178;177;177	C;G,A;G,A,T	173;172,2;171,1,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	1	SNP	p	D121N	0	.	.	361	363	GAC	700	703	CGC	174;174;175	C,G,T;G,C,A;C	168,1,1;167,2,1;167	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2058	porB1b	1041	1041	97.32	porB1b.l15.c30.ctg.1	1594	126.9	1	SNP	p	A121D	1	.	.	361	363	GAC	700	703	CGC	174;174;175	C,G,T;G,C,A;C	168,1,1;167,2,1;167	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7194	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4811	148.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	830	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1139	72.0	1	SNP	p	V57M	1	.	.	169	171	ATG	574	576	ATG	173;174;177	A;T;G,A	170;172;174,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
